Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families.

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Abstract Text:

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Human mutation

VOLUME: Suppl 1

Page Numbers: S117-20

Journal Abbreviation: Hum. Mutat.

ISSN: 1059-7794

DAY: 27

MONTH: 08

YEAR: 1998

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9215429

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Keywords Mesh Terms:

KEYWORDS: TRPP Cation Channels

MESH TERMS: genetics

Chemical & Substance for Abstract: Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families. Information

Substance Name: Deoxyribonucleases, Type II Site-Specifi

Registry Number: EC 3.1.21.4

Grant and Affiliation Information for Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families.

AFFILIATION: Servei de Nefrologia, Hospital Clínic, Villarroel, Barcelona, Spain.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Mutat

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families Related Publications

• A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
• A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart.
• Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.
• Alu-splice PCR: a simple method to isolate exon-containing fragments from cloned human genomic DNA.
• Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.
• Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders.
• Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients.
• Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.
• Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa.
• Detection of unrecognized low-level mtDNA heteroplasmy may explain the variable phenotypic expressivity of apparently homoplasmic mtDNA mutations.
• Extensive Genotyping of the BDNF and NTRK2 Genes Define Protective Haplotypes Against Obsessive-Compulsive Disorder.
• Functional genomics of Down syndrome: a multidisciplinary approach.
• Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.
• Identification of two new nonsense mutations (Q311X and W326X) in Exon 2 of the adrenoleukodystrophy (ALD) gene.
• MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene.
• Probe-specific mixed-model approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA).
• Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families.
• Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin.
• [Large-scale genotyping in research into autism spectrum disorders and attention deficit hyperactivity disorder.]